Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F9R27
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,249
Award facts
- Contract value 100% obligated
- $3,248.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 19, 2025, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The product will be delivered to the company's corporate office location in Conshohocken, PA.
Benlysta (belimumab) is a biologic immunosuppressive medication used to treat systemic lupus erythematosus and other autoimmune conditions. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within DLA's comprehensive global pharmaceutical support program, which supplies specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide. The company's competitively awarded contract portfolio demonstrates its capability to fulfill diverse federal medical supply requirements, ranging from routine pharmaceutical orders to specialized biologics and auto-injector devices.
Quick answers
Who was awarded contract SPE2DR26F9R27?
SPE2DR26F9R27 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F9R27 worth?
The government has obligated $3,249 on SPE2DR26F9R27.
Is contract SPE2DR26F9R27 an order under another contract?
Yes. SPE2DR26F9R27 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9R27 competed?
The extent of competition for SPE2DR26F9R27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award